A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects-Reference-Cited by-同舟云学术

A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects

Published:2016-06-21 Issue:6 Volume:11 Page:e0157335
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Greenberg Richard N.,Hay Christine M.,Stapleton Jack T.,Marbury Thomas C.,Wagner Eva,Kreitmeir Eva,Röesch Siegfried^ORCID,von Krempelhuber Alfred,Young Philip,Nichols Richard,Meyer Thomas P.,Schmidt Darja^ORCID,Weigl Josef,Virgin Garth,Arndtz-Wiedemann Nathaly,Chaplin Paul

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. The confirmation and maintenance of smallpox eradication;JG Breman;N Engl J Med,1980

2. Smallpox vaccination and bioterrorism with pox viruses;A Mayr;Comp Immun Microbiol Infect Dis,2003

3. Smallpox vaccines for biodefense: need and feasibility;AW Artenstein;Expert Rev Vaccines,2008

4. Complications of smallpox vaccination, 1968;JM Lane;N Engl J Med,1969

5. Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968;JM Lane;JAMA,1970

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine;Human Vaccines & Immunotherapeutics;2024-08-22

2. Serologic responses to the MVA-based JYNNEOS mpox vaccine in a cohort of participants from the District of Columbia (D.C.);Vaccine;2024-07

3. Predicting vaccine effectiveness for mpox;Nature Communications;2024-05-08

4. WITHDRAWN: Monkeypox: A Timely Update on the Global Outbreak, Transmission, Viral Replication, Vaccination and Clinical Strategies;Supramolecular Materials;2024-05

5. A Quadrivalent mRNA Immunization Elicits Potent Immune Responses against Multiple Orthopoxviral Antigens and Neutralization of Monkeypox Virus in Rodent Models;Vaccines;2024-04-05